目的以全国范围内非选择性人群为研究对象,探讨连续三次血压测量间的血压变异性及其影响因素。方法对2017年"五月血压测量月"项目中国区域数据(n=77 549)进行分析,所有受试者测量三次诊室血压,以收缩压标准差(SBPSD)、舒张压...目的以全国范围内非选择性人群为研究对象,探讨连续三次血压测量间的血压变异性及其影响因素。方法对2017年"五月血压测量月"项目中国区域数据(n=77 549)进行分析,所有受试者测量三次诊室血压,以收缩压标准差(SBPSD)、舒张压标准差(DBPSD)、收缩压变异系数(SBPV)、舒张压变异系数(DBPV)作为评估血压变异性的指标。结果研究显示,非所有的第三次血压均较第一次降低,14%的参与者第三次测量的收缩压较第一次增高5 mm Hg或以上。女性SBPV和DBPV高于男性[(4.2±3.3)%比(4.1±3.3)%,(4.7±4.0)%比(4.6±4.1)%;P<0.05]。不同年龄、血压级别组SBPSD、DBPSD、SBPV、DBPV差异有统计学意义(均P<0.01)。经多元线性回归分析发现,SBPSD和SBPV与年龄呈负相关,与第一次收缩压读数呈正相关,女性SBPSD和SBPV较男性高(均P<0.01)。结论并非所有血压均随着测量次数的增加而下降。三次血压测量间存在变异性,血压变异性与年龄、性别及血压水平相关。展开更多
Objective: To observe the immediate effect and safety of Shexiang Tongxin dropping pills(麝香通心滴丸, STDP) on patients with coronary slow flow(CSF), and furthermore, to explore new evidence for the use of Chinese me...Objective: To observe the immediate effect and safety of Shexiang Tongxin dropping pills(麝香通心滴丸, STDP) on patients with coronary slow flow(CSF), and furthermore, to explore new evidence for the use of Chinese medicine in treating ischemic chest pain. Methods: Coronary angiography(CAG) with corrected thrombolysis in myocardial infarction(TIMI) frame count(CTFC) was applied(collected at 30 frames/s). The treatment group included 22 CSF patients, while the control group included 22 individuals with normal coronary?ow. CSF patients were given 4 STDP through sublingual administration, and CAG was performed 5 min after the medication. The immediate blood ?ow frame count, blood pressure, and heart rate of patients before and after the use of STDP were compared. The liver and kidney functions of patients were examined before and after treatments. Results: There was a signi?cant difference in CTFC between groups(P<0.05). The average CTFC values of the vessels with slow blood ?ow in CSF patients were, respectively, 49.98±10.01 and 40.42±11.33 before and after the treatment with STDP, a 19.13% improvement. The CTFC values(frame/s) measured before and after treatment at the left anterior descending coronary artery, left circumflex artery, and right coronary artery were, respectively, 48.00±13.32 and 41.80±15.38, 59.00±4.69 and 50.00±9.04, and 51.90±8.40 and40.09±10.46, giving 12.92%, 15.25%, and 22.76% improvements, respectively. The CTFC values of vessels with slow ?ow before treatment were signi?cantly decreased after treatment(P<0.05). There were no apparent changes in the heart rate, blood pressure, or liver or kidney function of CSF patients after treatment with STDP(all P>0.05). Conclusions: The immediate effect of STDP in treating CSF patients was apparent. This medication could signi?cantly improve coronary ?ow without affecting blood pressure or heart rate. Our ?ndings support the potential of Chinese medicine to treat ischemic chest pain.展开更多
文摘目的以全国范围内非选择性人群为研究对象,探讨连续三次血压测量间的血压变异性及其影响因素。方法对2017年"五月血压测量月"项目中国区域数据(n=77 549)进行分析,所有受试者测量三次诊室血压,以收缩压标准差(SBPSD)、舒张压标准差(DBPSD)、收缩压变异系数(SBPV)、舒张压变异系数(DBPV)作为评估血压变异性的指标。结果研究显示,非所有的第三次血压均较第一次降低,14%的参与者第三次测量的收缩压较第一次增高5 mm Hg或以上。女性SBPV和DBPV高于男性[(4.2±3.3)%比(4.1±3.3)%,(4.7±4.0)%比(4.6±4.1)%;P<0.05]。不同年龄、血压级别组SBPSD、DBPSD、SBPV、DBPV差异有统计学意义(均P<0.01)。经多元线性回归分析发现,SBPSD和SBPV与年龄呈负相关,与第一次收缩压读数呈正相关,女性SBPSD和SBPV较男性高(均P<0.01)。结论并非所有血压均随着测量次数的增加而下降。三次血压测量间存在变异性,血压变异性与年龄、性别及血压水平相关。
基金Supported by the Zhejiang Institute of Integrative Medicine Clinical Special Fund for Pharmacy Research(No.2014LYK009)
文摘Objective: To observe the immediate effect and safety of Shexiang Tongxin dropping pills(麝香通心滴丸, STDP) on patients with coronary slow flow(CSF), and furthermore, to explore new evidence for the use of Chinese medicine in treating ischemic chest pain. Methods: Coronary angiography(CAG) with corrected thrombolysis in myocardial infarction(TIMI) frame count(CTFC) was applied(collected at 30 frames/s). The treatment group included 22 CSF patients, while the control group included 22 individuals with normal coronary?ow. CSF patients were given 4 STDP through sublingual administration, and CAG was performed 5 min after the medication. The immediate blood ?ow frame count, blood pressure, and heart rate of patients before and after the use of STDP were compared. The liver and kidney functions of patients were examined before and after treatments. Results: There was a signi?cant difference in CTFC between groups(P<0.05). The average CTFC values of the vessels with slow blood ?ow in CSF patients were, respectively, 49.98±10.01 and 40.42±11.33 before and after the treatment with STDP, a 19.13% improvement. The CTFC values(frame/s) measured before and after treatment at the left anterior descending coronary artery, left circumflex artery, and right coronary artery were, respectively, 48.00±13.32 and 41.80±15.38, 59.00±4.69 and 50.00±9.04, and 51.90±8.40 and40.09±10.46, giving 12.92%, 15.25%, and 22.76% improvements, respectively. The CTFC values of vessels with slow ?ow before treatment were signi?cantly decreased after treatment(P<0.05). There were no apparent changes in the heart rate, blood pressure, or liver or kidney function of CSF patients after treatment with STDP(all P>0.05). Conclusions: The immediate effect of STDP in treating CSF patients was apparent. This medication could signi?cantly improve coronary ?ow without affecting blood pressure or heart rate. Our ?ndings support the potential of Chinese medicine to treat ischemic chest pain.